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There is compelling support for widening the role of computed tomography (CT) for
COVID-19 in clinical and research scenarios. Reverse transcription polymerase chain
reaction (RT-PCR) testing, the gold standard for COVID-19 diagnosis, has two potential
weaknesses: the delay in obtaining results and the possibility of RT-PCR test kits running
out when demand spikes or being unavailable altogether. This perspective article
discusses the potential use of CT in conjunction with RT-PCR in hospitals lacking
sufficient access to RT-PCR test kits. The precedent for this approach is discussed
based on the use of CT for COVID-19 diagnosis and screening in the United Kingdom and
China. The hurdles and challenges are presented, which need addressing prior to
realization of the potential roles for CT artificial intelligence (AI). The potential roles
include a more accurate clinical classification, characterization for research roles and
mechanisms, and informing clinical trial response criteria as a surrogate for clinical
outcomes.
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INTRODUCTION
Computed tomography (CT) is not being used to its full potential toward a better understanding
of COVID-19. The reverse transcription polymerase chain reaction (RT-PCR) test is the current
gold standard for diagnosing COVID-19 through the detection of nucleic acid present in SARS-
CoV-2, the virus that causes COVID-19 (Ai et al., 2020). One of the main disadvantages with
RT-PCR testing is that the results may take several hours to several days to obtain. Another
disadvantage is that RT-PCR test kits are a finite resource. In many instances, test kits have
become temporarily limited in areas experiencing outbreaks as the demand has spiked. Moreover,
in low- and middle-income countries, it has been a struggle to access test kits altogether or in the
quantity needed (Peplow, 2020). Any hospital equipped with a CT scanner could potentially use
CT in conjunction with RT-PCR to address these problems. In specific high-prevalence settings
early in the pandemic, the sensitivity of chest CT for detecting COVID-19 has been reported as
high as 97–98%, compared to 71–85% for early real-time reverse transcriptase polymerase chain
reaction (rRT-PCR) (Ai et al., 2020; Bernheim et al., 2020; Kanne, 2020; Xie et al., 2020). There
has been much debate over the ability to generalize such high performance numbers, which are
highly dependent on background prevalence in the community or screening population, clinical
suspicion, and the performance of specific RT-PCR methodologies, which has improved over the
past year.
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To complement the use of standard chest CT for COVID-19
characterization and to further contribute to the body of
knowledge for combating the pandemic, artificial intelligence
(AI) could be utilized to improve the ability of CT to swiftly
and accurately flag CTs for immediate interpretation,
characterize COVID-19 for clinical research, such as response
to medical countermeasures, and potentially increase patient
safety by optimizing radiation exposure.
THE ROLE OF CT IN THE COVID-19
PANDEMIC
Using CT in Conjunction With RT-PCR for
COVID-19 Diagnosis
To address the aforementioned weaknesses of RT-PCR
(namely, the delay in results and fluctuating availability), CT
could be used in conjunction with RT-PCR in selected target
populations with a high risk for COVID-19, such as at the point
of care (POC) in an outbreak setting. In such a POC setting, CT
could be used to identify possible cases, and RT-PCR would be
used to confirm conclusive diagnosis. CT might solve the
problem of delayed results because CT results with or
without AI models are obtained more quickly compared to
RT-PCR. CT scanners are widely available and offer reliable
daily accessibility. Moreover, CT has been shown to assist
with detecting possible cases of COVID-19, even among
asymptomatic patients, which may be important given the
public health conundrum of presymptomatic and asymptomatic
transmission (Apostolopoulos and Bessiana, 2003; Narin et al.,
2003; Wang and Wong, 2003; Bernheim et al., 2020; Kanne,
2020; Liang, 2020; Xie et al., 2020). Some studies have touted
the sensitivity of chest CT (vs. RT-PCR) for detecting
COVID-19 in super-acute high-prevalence early epidemic
outbreak settings (Ai et al., 2020; Liu et al., 2020). Another
study found that RT-PCR and CT together may miss fewer
patients than CT alone or RT-PCR alone (Inui et al., 2020).
Certain high-risk patients who undergo CT in an outbreak
setting or after a high dose exposure might be identified by CT
and isolated or quarantined while they await RT-PCR results,
thus reducing the risk of transmission (Amalou et al., 2020). CT
scans for other indications, performed in asymptomatic patients,
might also identify and isolate patients prior to risking
transmission to a busy clinic POC setting. This is important
because many people infected with SARS-CoV-2 have mild
symptoms or no symptoms at all. Additionally, peak viral
shedding occurs at or just before the onset of symptoms (Zou
et al., 2020), so it is common for asymptomatic people to
unknowingly transmit the disease and those patients may
have CT opacities (Varble et al., 2021). CT should not replace
RT-PCR for the diagnosis of SARS-CoV-2/COVID-19, so its
use might be tightly linked to RT-PCR availability, and the
risk-to-benefit ratios of the radiation risk vs. the risk to the
population of not diagnosing or isolating a particular patient.
CT might also be proposed as an epidemiology tool to assess
spread or focus on a target population who has exposure history,
such as a cruise ship.
Precedent
There is a precedent for widening the role of chest CT in COVID-
19 evaluation. Although some US and UK guidelines have
recommended against using chest CT for screening
(NHCotPsRo, 2019; Long et al., 2020), other countries have
applied chest CT to specific outbreak settings with a more
widespread, targeted, and strategic use of chest CT. In Chinese
outbreak settings, for example, chest CT of high-risk populations,
alongside of strict public health containment strategies, may have
contributed to successful containment and low mortalities. In the
US and Europe, chest CT has mainly been used to examine
patients later in the disease cycle, such as to screen for
complications or superinfections. In contrast, chest CT was
used frequently along with RT-PCR for acute diagnosis in
“fever clinics” in Hubei Province, China (Liang, 2020). For a
brief and transient period during a high outbreak setting,
COVID-19 diagnoses were made based on positive CT and a
recent high-risk travel or possible exposure, even when the
FIGURE 1 | CT images of the lungs in a subject with COVID-19. (A–C)
Original CT images. (D–F) CT images with AI segmentation of COVID-19 lung
opacities.
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patients’ RT-PCR results were initially negative (NHCotPsRo,
2019). Thus, CT has been aggressively applied alongside of RT-
PCR in an outbreak setting as an epidemiology tool for optimized
contact tracing.
Furthermore, early in the pandemic, the United Kingdom
provided intercollegiate guidelines stating that patients
undergoing elective surgery required chest CT beforehand if
the procedures were high risk or if the patients were expected
to require admission to the intensive therapy unit or high
dependency unit postoperatively (Standards and Clinical Gu,
2020). Additionally, for patients presenting with abdominal
symptoms and undergoing CT evaluation of the abdomen and
pelvis, CT coverage of the chest also was recommended early in
the pandemic (Bullock et al., 2020).
Potential Roles of Artificial Intelligence in
CT Optimization
AI is a promising tool to increase the potential suitability of chest
CT for COVID-19 screening, detection, monitoring, and research
in certain highly constrained settings. AI has already been applied
in many technologies developed in response to the emergence of
COVID-19 (Bullock et al., 2020), including lung and infection
segmentation, COVID-19 quantification, and techniques for
clinical classification, detection, assessment, and monitoring.
Figure 1 shows an example of how AI segmentation models
for COVID-19 can be applied to chest CT.
Currently, a common recommendation among medical and
public health organizations is that CT should not be used for
screening, and it should only be used for COVID-19 in patients
with moderate to severe symptoms of COVID-19, worsening
respiratory status, or indications of cardiopulmonary
complications, and only when RT-PCR is unavailable or RT-
PCR access is highly limited. Despite the high sensitivity of chest
CT for COVID-19 in high-prevalence settings, one reason why
chest CT is not more widely recommended for COVID-19
diagnosis is that the imaging findings are nonspecific,
overlapping with many other diseases such as influenza,
H1N1, SARS, MERS, and pneumonias with underlying causes
other than SARS-CoV-2 (A. C. O. Radiology, 2020; C. F. D. C. A.
Prevention, 2020). One study found that two standardized
grading systems for determining the suspicion level of
COVID-19 pneumonia based on chest CT had good inter-
reader agreement among experienced readers but only
moderate inter-reader agreement among less experienced
readers (Sushentsev et al., 2020). To increase specificity and
reduce the analytical burden on radiologists, AI could be
utilized to learn the unique characteristics of chest CT in
COVID-19 compared to other diseases (Roberts et al., 2021).
This would be especially useful for smaller medical centers that
lack dedicated, experienced radiologists and for out-of-hours
scanning. Standardized AI initial interpretations might also
reduce the subjectivity or interobserver variability of a
subsequent radiologist review.
Lin et al. (2021) investigated differences in CT characteristics,
some of which were determined by AI software, between patients
with COVID-19 pneumonia and influenza virus pneumonia.
Although they identified four CT characteristics with statistical
differences, they concluded it might still be difficult to
differentiate between the two causes of pneumonia in clinical
practice.
In a particularly promising study by Harmon et al. (2020), a
series of deep learning algorithms were used to assist chest CT in
distinguishing between COVID-19 pneumonia and non-
COVID-19 pneumonia. The algorithms were trained in a
cohort of 1,280 patients and tested in an independent set of
1,337 patients. The resulting classification of COVID-19
pneumonia had an accuracy of >90%, sensitivity of 84%, and
specificity of 93%. Among 140 patients with laboratory confirmed
non-COVID-19 pneumonia in the test set, the false positive rate
of the AI-assisted chest CT was 10%.
However, the overall pool of research on AI-assisted chest CT
is at a very early stage, with many limitations, generalizations,
overfit models, and reproduction of similar models. Image-based
AI models abound that lack external validation, clinical metadata
and relevant clinical labs, phase of disease parameters, or
background prevalence data. Two separate reviews on this
research topic have highlighted the shortcomings. One was a
systematic review on machine learning literature related to the
use of CT and CXR imaging for COVID-19 diagnosis and
prognosis (Roberts et al., 2021). It did not find any articles
that satisfied all three key criteria for clinical translation of
research: sufficiently documented and reproducible methods,
methods adhering to best practices for machine learning
model development, and proper external validation. The other
review was on the use of AI with chest CT to diagnose COVID-19
(Ozsahin et al., 2020). It found that the majority of studies on this
topic were not peer-reviewed. Additionally, some studies had
extremely limited data and some used data from different
institutions and scanners, but did not carry out the necessary
preprocessing of the data to increase the consistency across data
from different sources. Furthermore, some studies lacked
sufficient demographic or clinical information for the patients.
The two review articles agree that larger and higher quality
datasets will be of the utmost importance for future studies in
the field. COVID-Net aims to accelerate research in the field by
releasing open-source, open-access deep learning models and
networks created for AI-assisted chest CT for various COVID-19
related tasks (e.g., screening and treatment monitoring) as well as
large, diverse datasets (Wong, 2020). Federated learning
incentivizes and facilitates data sharing by removing certain
privacy barriers, which have variable rules and processes
throughout the world. With federated learning, the deep
learning model weights can be shared without actual data
exchange, without compromising the AI training process
(Yang et al., 2021).
One of the risks associated with CT imaging is radiation
exposure. Regarding patient safety, AI-based estimations of
body region thickness could calculate optimal X-ray exposure
parameters and AI-generalized adversarial networks could
facilitate low-dose imaging. The population risks of more
broadly using chest CT scans for enhanced indications in
COVID-19 remain to be defined or fully justified for specific
settings and remain a concern.
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Looking forward, AI could be used to improve the sensitivity
and efficiency of chest CT for detecting COVID-19 and to
increase the effectiveness of CT as a disease response or a
monitoring tool for both research and clinical practice. AI
could further enhance the ability of CT to provide
quantification of objective biomarkers of response to
experimental treatment programs for specific cohorts of
patients. AI could also help optimize the CT image quality
through the development of automated, high-precision Iso-
centering and scan range determination.
CT AI might provide a standardized measure and surrogate
biomarker metric for lung disease. Speculative uses of CT AI
include the measurement of clinical response to therapeutics like
steroids, monoclonal antibodies, or anti-inflammatory
medications. It is unknown whether CT AI could help identify
chronic lung changes in chronic COVID-19 breathlessness,
variant-specific features, or early detection of at-risk phases of
disease exacerbations (either primary infectious opacities or
immune or inflammatory phase reactions). We have a lot to
learn and CT AI adds a tool to the discovery toolbox.
CONCLUSION
In conclusion, there are compelling reasons to be attracted
toward studying chest CT as a tool for developing a better
understanding of COVID-19. Clinical public health and
research goals for COVID-19 might be enlightened by a
targeted application of chest CT and CT AI to seeking
answers for specific clinical and research questions in specific
outbreak or therapeutic settings. Additional research and data
are required to determine the exact roles of chest CT in early
detection, classification, and triage of resource-limited therapies,
and its potential role as an epidemiology tool in limited targeted
populations. The pandemic has proved to be an “AI-instigator”;
however, AI-assisted CT tools will require more rigorous
academic development, broader clinical metadata, and more
thorough critical review in hopes of more generalized tools
with clinical or research relevance. We can do better. The
times demand it.
DATA AVAILABILITY STATEMENT
The original contributions presented in the study are included in
the article; further inquiries can be directed to the corresponding
author.
AUTHOR CONTRIBUTIONS
ZT, SH, and HR wrote the article. TB, SX, and BW conceived the
ideas and edited the article.
FUNDING
This study was supported in part by the Royal Society Wolfson
Fellowship, the National Institutes of Health (NIH) Bench-to-
Bedside Award, the NIH Center for Interventional Oncology
Grant, the National Science Foundation (NSF) I-Corps Team
Grant (1617340), NSF REU site program 1359095, the UGA-AU
Inter-Institutional Seed Funding, the American Society for
Quality Dr. Richard J. Schlesinger Grant, the PHS Grant
UL1TR000454 from the Clinical and Translational Science
Award Program, the NIH National Center for Advancing
Translational Sciences, the NIH Center for Interventional
Oncology (Grant ZID# BC011242 and CL040015), the
Intramural Research Program of the National Institutes of
Health, and the Intramural Targeted Anti-COVID (ITAC)
Program of the National Institute of Allergy and Infectious
Diseases.
REFERENCES
A. C. O. Radiology (2020). ACR Recommendations for the Use of Chest
Radiography and Computed Tomography (CT) for Suspected COVID-19
Infection. Available: https://www.acr.org/Advocacy-and-Economics/ACR-
Position-Statements/Recommendations-for-Chest-Radiography-and-CT-for-
Suspected-COVID19-Infection (Accessed March 31, 2021).
Ai, T., Yang, Z., Hou, H., Zhan, C., Chen, C., Lv, W., et al. (2020). Correlation of
Chest CT and RT-PCR Testing for Coronavirus Disease 2019 (COVID-19) in
China: A Report of 1014 Cases. Radiology 296 (2), E32–E40. doi:10.1148/
radiol.2020200642
Amalou, A., Türkbey, B., Sanford, T., Harmon, S., Türkbey, E. B., Xu, S., et al.
(2020). Targeted Early Chest CT in COVID-19 Outbreaks as Diagnostic Tool
for Containment of the Pandemic- A Multinational Opinion. Diagn. Interv.
Radiol. 26 (4), 04–24. doi:10.5152/dir.2020.20231
Apostolopoulos, I. D., and Bessiana, T. (2003). Covid-19: Automatic Detection from
X-Ray Images Utilizing Transfer Learning with Convolutional Neural Networks.
arXiv, 11617.
Bernheim, A., Mei, X., Huang, M., Yang, Y., Fayad, Z. A., and Zhang, N. (2020).
Chest CT Findings in Coronavirus Disease-19 (COVID-19): Relationship to
Duration of Infection. Radiology 295, 200463.
Bullock, J., Luccioni, A., Pham, K. H., Lam, C. S. N., and Luengo-Oroz, M. (2020).
Mapping the Landscape of Artificial Intelligence Applications against COVID-19.
arXiv:2003.11336.
C. F. D. C. A. Prevention (2020). Interim Clinical Guidance for Management of
Patients with Confirmed Coronavirus Disease (COVID-19). Available: https://
www.cdc.gov/coronavirus/2019-ncov/hcp/clinical-guidance-management-
patients.html (Accessed March 31, 2021).
Harmon, S. A., Sanford, T. H., Xu, S., Turkbey, E. B., Roth, H., Xu, Z., et al. (2020).
Artificial Intelligence for the Detection of COVID-19 Pneumonia on Chest CT
Using Multinational Datasets. Nat. Commun. 11 (1), 4080. doi:10.1038/s41467-
020-17971-2
Inui, S., Fujikawa, A., Jitsu, M., Kunishima, N., Watanabe, S., Suzuki, Y., et al.
(2020). Chest CT Findings in Cases from the Cruise Ship Diamond Princess
with Coronavirus Disease (COVID-19). Radiol. Cardiothorac. Imaging 2 (2),
e200110. doi:10.1148/ryct.2020200110
Kanne, J. P. (2020). Chest CT Findings in 2019 Novel Coronavirus (2019-nCoV)
Infections from Wuhan, China: Key Points for the Radiologist. Radiology 295,
16–17.
Liang, T. (2020). Handbook of COVID-19 Prevention and Treatment: The First
Affiliated Hospital. Zhejiang University School of Medicine.
Lin, L., Fu, G., Chen, S., Tao, J., Qian, A., Yang, Y., et al. (2021). CT Manifestations
of Coronavirus Disease (COVID-19) Pneumonia and Influenza Virus
Frontiers in Artificial Intelligence | www.frontiersin.org July 2021 | Volume 4 | Article 5901894
Tse et al. AI-Assisted CT COVID-19 Diagnosis
Pneumonia: A Comparative Study. Am. J. Roentgenology 216 (1), 71–79.
doi:10.2214/ajr.20.23304
Liu, J., Yu, H., and Zhang, S. (2020). The Indispensable Role of Chest CT in the
Detection of Coronavirus Disease 2019 (COVID-19). Eur. J. Nucl. Med. Mol.
Imaging 47, 1638–1639. doi:10.1007/s00259-020-04795-x
Long, C., Xu, H., Shen, Q., Zhang, X., Fan, B., Wang, C., et al. (2020). Diagnosis of
the Coronavirus Disease (COVID-19): rRT-PCR or CT? Eur. J. Radiol. 126,
108961. doi:10.1016/j.ejrad.2020.108961
Narin, A., Kaya, C., and Pamuk, Z. (2003). Automatic Detection of Coronavirus
Disease (COVID-19) Using X-ray Images and Deep Convolutional Neural
Networks. arXiv, 10849.
NHCotPsRo, C. (2019). Diagnosis and Treatment Protocols of Pneumonia Caused
by a Novel Coronavirus (Trial Version 5). Available: http://www.nhc.gov.cn/
yzygj/s7653p/202002/3b09b894ac9b4204a79db5b8912d4440.shtml.
Ozsahin, I., Sekeroglu, B., Musa, M. S., Mustapha, M. T., and Uzun Ozsahin, D.
(2020). Review on Diagnosis of COVID-19 from Chest CT Images Using
Artificial Intelligence. Comput. Math. Methods Med. 2020, 1–10. doi:10.1155/
2020/9756518
Peplow, M. (2020). Developing Countries Face Diagnostic Challenges as the
COVID-19 Pandemic Surges. Chemical & Engineering News. Available:
https://cen.acs.org/analytical-chemistry/diagnostics/Developing-countries-
face-diagnostic-challenges/98/i27 (Accessed April 11, 2021).
Roberts, M., Driggs, D., Thorpe, M., Gilbey, J., Yeung, M., Ursprung, S., et al.
(2021). Common Pitfalls and Recommendations for Using Machine
Learning to Detect and Prognosticate for COVID-19 Using Chest
Radiographs and CT Scans. Nat. Mach Intell. 3 (3), 199–217.
doi:10.1038/s42256-021-00307-0
Standards and Clinical Guidelines (2020). British Society of Gastrointestinal and
Abdominal Radiology and British Society of Thoracic Imaging - Covid-19:
BSTI/BSGAR Decision Tool for Chest Imaging in Patients Undergoing CT for
Acute Surgical Abdomen. Available: https://www.bsti.org.uk/media/resources/files/
BSGAR_BSTI_joint_decision_tool_for_CT_v1_FINAL_25.03.20_CM7VQla.pdf.
Sushentsev, N., Bura, V., Kotnik, M., Shiryaev, G., Caglic, I., Weir-McCall, J., et al.
(2020). A Head-To-Head Comparison of the Intra- and Interobserver
Agreement of COVID-RADS and CO-RADS Grading Systems in a
Population with High Estimated Prevalence of COVID-19. BJR open 2 (1),
20200053. doi:10.1259/bjro.20200053
Varble, N., Blain, M., Kassin, M., Xu, S., Turkbey, E. B., Amalou, A., et al. (2021).
CT and Clinical Assessment in Asymptomatic and Pre-symptomatic Patients
with Early SARS-CoV-2 in Outbreak Settings. Eur. Radiol. 31 (5), 3165–3176.
doi:10.1007/s00330-020-07401-8
Wang, L., and Wong, A. (2003). COVID-net: A Tailored Deep Convolutional
Neural Network Design for Detection of COVID-19 Cases from Vhest
Radiography Images. arXiv, 09871.
Wong, A. S. (2020). COVID-net. Available: https://alexswong.github.io/COVID-
Net/ (Accessed May 14, 2021).
Xie, X., Zhong, Z., Zhao, W., Zheng, C., Wang, F., and Liu, J. J. R. (2020). Chest CT
for Typical 2019-nCoV Pneumonia: Relationship to Negative RT-PCR Testing.
Radiology 296, E41–E45.
Yang, D., Xu, Z., Li, W., Myronenko, A., Roth, H. R., Harmon, S., et al. (2021).
Federated Semi-supervised Learning for COVID Region Segmentation in Chest
CT Using Multi-National Data from China, Italy, Japan. Med. image Anal. 70,
101992. doi:10.1016/j.media.2021.101992
Zou, L., Ruan, F., Huang, M., Liang, L., Huang, H., Hong, Z., et al. (2020). SARS-
CoV-2 Viral Load in Upper Respiratory Specimens of Infected Patients.N. Engl.
J. Med. 382, 1177–1179. doi:10.1056/NEJMc2001737
Disclaimer: The content of this manuscript does not necessarily reflect the views,
policies, or opinions of the U.S. Department of Health and Human Services nor the
National Institutes of Health. Themention of commercial products, their source, or
their use in connection with material reported herein is not to be construed as an
actual or implied endorsement of such products by the United States government.
Opinions expressed are those of the authors, not necessarily the NIH. NIH has a
cooperative research and development agreement with Philips, Siemens, and
Canon Medical. Canon Medical and NIH have a licensing agreement for a
software algorithm related to classification of COVID-19 on chest CT.
Conflict of Interest: The authors declare that the research was conducted in the
absence of any commercial or financial relationships that could be construed as a
potential conflict of interest.
Copyright © 2021 Tse, Hovet, Ren, Barrett, Xu, Turkbey andWood. This is an open-
access article distributed under the terms of the Creative Commons Attribution
License (CC BY). The use, distribution or reproduction in other forums is permitted,
provided the original author(s) and the copyright owner(s) are credited and that the
original publication in this journal is cited, in accordance with accepted academic
practice. No use, distribution or reproduction is permitted which does not comply
with these terms.
Frontiers in Artificial Intelligence | www.frontiersin.org July 2021 | Volume 4 | Article 5901895
Tse et al. AI-Assisted CT COVID-19 Diagnosis
